drugset / Trial / NCT05162222

A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicamtiv in Healthy Participants

NCT05162222

Phase 1 Completed 30 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of co-administration of itraconazole or diltiazem on the single-dose pharmacokinetics of danicamtiv in healthy participants.

Timeline

Start
2021-12-15
Primary completion
2022-07-08
Completion
2022-07-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Danicamtiv Small molecule
Subject Diltiazem Small molecule
Subject Itraconazole Small molecule

Indications

No indication recorded.